Myasthenia gravis represents chronic autoimmune disease that primarily targets the neuromuscular junction. This junction enables the transmission of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, resulting weakness and fatigue in the motor units. The manifestat